The wind of change - PCSK9 inhibitors in hypolipidemic treatment. The Polish perspective
Introduction and aim. Cardiovascular diseases are the main cause of mortality in the world. One of the alterable risk factors of ischaemic heart disease is dyslipidemia. Discovery and usage of a new group of drugs - PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors lead to a decrease...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Kazimierz Wielki University,
2023-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|